Registered entities
Alpine Immune Sciences, Inc.
Reg. No. 1626199United States
ALPINE IMMUNE SCIENCES, INC
Reg. No. 20-8969493United States
Innovation
24 patent families (17 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 17,957 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 10 |
| 2019 | 13 |
| 2020 | 10 |
| 2021 | 13 |
| 2022 | 11 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 15 |
| 2026 | 6 |
Investor mix
12 investors on record; lead investors include Alpine Bioventures; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 58% |
| Private equity | 3 | 25% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 1 | 8% |